SRP9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.372800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.913200E-01
Normal-vs-Stage2
9.696200E-01
Normal-vs-Stage3
4.289200E-01
Normal-vs-Stage4
7.502200E-01
Stage1-vs-Stage2
1.519200E-01
Stage1-vs-Stage3
1.347000E-01
Stage1-vs-Stage4
6.135600E-01
Stage2-vs-Stage3
2.940800E-01
Stage2-vs-Stage4
6.689600E-01
Stage3-vs-Stage4
3.557600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.953000E-01
Normal-vs-AfricanAmerican
3.052200E-01
Normal-vs-Asian
7.279800E-01
Caucasian-vs-AfricanAmerican
7.770500E-02
Caucasian-vs-Asian
4.506200E-01
AfricanAmerican-vs-Asian
3.884000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.186400E-01
Normal-vs-Female
9.362600E-01
Male-vs-Female
9.079200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.053400E-01
Normal-vs-Age(41-60Yrs)
7.266600E-01
Normal-vs-Age(61-80Yrs)
9.965200E-01
Normal-vs-Age(81-100Yrs)
9.065800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.230800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.177200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.293000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.551800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.025600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.278600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.737200E-01
Normal-vs-Daily Drinker
6.021800E-01
Normal-vs-Weekly Drinker
6.514400E-01
Normal-vs-Occasional Drinker
3.726800E-01
Normal-vs-Social Drinker
8.869600E-01
Non Drinker-vs-Daily Drinker
3.011400E-01
Non Drinker-vs-Weekly Drinker
5.142600E-01
Non Drinker-vs-Occasional Drinker
9.952400E-02
Non Drinker-vs-Social Drinker
7.178400E-01
Daily Drinker-vs-Weekly Drinker
7.663800E-01
Daily Drinker-vs-Occasional Drinker
1.342360E-02
Daily Drinker-vs-Social Drinker
2.605400E-01
Weekly Drinker-vs-Occasional Drinker
2.731700E-02
Weekly Drinker-vs-Social Drinker
4.061600E-01
Occasional Drinker-vs-Social Drinker
3.384400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.452500E-02
Normal-vs-Grade 2
6.515800E-03
Normal-vs-Grade 3
4.598000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.970400E-01
Grade 1-vs-Grade 3
9.504600E-01
Grade 1-vs-Grade 4
6.452500E-02
Grade 2-vs-Grade 3
9.323600E-01
Grade 2-vs-Grade 4
6.515800E-03
Grade 3-vs-Grade 4
4.598000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.019200E-01
Normal-vs-NonDiabetic
8.241800E-01
Diabetic-vs-NonDiabetic
1.681220E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.857200E-01
Normal-vs-NoPancreatitis
9.763000E-01
Pancreatitis-vs-NoPancreatitis
3.685600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.982400E-01
Normal-vs-N1
9.880600E-01
N0-vs-N1
1.832200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.720000E-01
Normal-vs-TP53-NonMutant
7.605200E-01
TP53-Mutant-vs-TP53-NonMutant
6.674400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
